Atorvastatin in Myeloma
NCT00164086 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2006-10-11
Summary
The purpose of this trial is to study the effects of a medication already widely used to treat cardiovascular disease and diabetes, in reducing the progression of myeloma.
Conditions
Interventions
- DRUG
Sponsors & Collaborators
-
Bayside Health
lead OTHER_GOV
Principal Investigators
-
Andrew Spencer, MBChB, FRACP, PhD · The Alfred
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- Australia
Study Locations
More Related Trials
-
A Study Examining Torcetrapib/Atorvastatin And Atorvastatin Effects On Clinical CV Events In Patients With Heart Disease
NCT00134264 ·Status: TERMINATED ·Phase: PHASE3
-
CARDS Is Designed To Show If Lowering Cholesterol With Atorvastatin In Type 2 Diabetics Without CV Disease Reduces The Risk Of CV Events
NCT00327418 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Bile Acid Diarrhoea With Atorvastatin
NCT07042165 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation of Atorvastatin Treatment on Carotid Plaque.
NCT00343655 ·Status: TERMINATED ·Phase: PHASE3
-
Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies
NCT00452842 ·Status: TERMINATED
-
Cardiopulmonary-bypass and Reno-protective Effect of Atorvastatin Trial
NCT00910221 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Drug-Drug Interaction Between Enlicitide Decanoate (MK-0616) and Atorvastatin in Healthy Adult Participants (MK-0616-024)
NCT06699355 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Atorvo+™ in Healthy Adult Participants
NCT06615284 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 40 mg (0653-090)
NCT00276484 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine
NCT01548326 ·Status: UNKNOWN ·Phase: PHASE4
-
Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients
NCT01013103 ·Status: COMPLETED ·Phase: PHASE4
-
LY2189265 and Atorvastatin Interaction Study
NCT01250834 ·Status: COMPLETED ·Phase: PHASE1
-
Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)
NCT00418834 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate Ezetimibe Plus Atorvastatin Versus Atorvastatin in Patients With High Cholesterol Not Controlled on Atorvastatin 20 mg (0653-079)(COMPLETED)
NCT00276458 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Atorvastatin Versus Placebo to Reduce Cardiopulmonary Complications After Thoracic Surgery
NCT00375518 ·Status: COMPLETED ·Phase: NA
-
Treating Tuberculosis With the Lipid Lowering Drug Atorvastatin in Nigeria(ATORvastatin in Pulmonary TUBerculosis)
NCT04721795 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Atorvastatin in Healthy Volunteers
NCT01115985 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients
NCT03611010 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease
NCT00293748 ·Status: COMPLETED
-
A Study of LY3478045 in Healthy Participants
NCT04270370 ·Status: COMPLETED ·Phase: PHASE1
-
Ezetimibe in Patients Hypo-responsive to Statins
NCT00965055 ·Status: TERMINATED ·Phase: PHASE3
-
STATIN: Web-based Investigation of Side Effects
NCT02781064 ·Status: COMPLETED ·Phase: PHASE4
-
Self-Assessment Method for Statin Side-effects Or Nocebo
NCT02668016 ·Status: COMPLETED ·Phase: PHASE4
-
Aggressive Cholesterol Therapy to Inhibit Vein Graft Events After CABG (ACTIVE Trial)
NCT01528709 ·Status: COMPLETED ·Phase: PHASE3
-
Bioavailability Study for New Atorvastatin Formulation
NCT00844376 ·Status: COMPLETED ·Phase: PHASE4